Safety and Efficacy Study of a Eye Drop for Eye Allergy

Completed · Phase 3 · Has a placebo group

Conditions studied: Allergic Conjunctivitis

In brief

The purpose of this study is to evaluate the efficacy and safety of an anti-allergy eyedrop.

Key facts

Study ID

NCT00889330

Run by

Vistakon Pharmaceuticals

People needed

60

Starts

2009-04-01

Last updated by the study team

2015-03-06

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 10 years of age
• positive history of ocular allergies
• positive skin test reaction to allergens.

You may not qualify if…

• known allergy, contraindication, or sensitivities to the use of any of the study medication(s) or their components
• ocular surgical intervention within three (3) months prior to visit 1 or during the study
• known history of retinal detachment, diabetic retinopathy, or progressive retinal disease, or glaucoma
• any other significant illness

Where it is running

• Study site — Fairfield, Ohio, United States
• Study site — Mason, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.